TCTMD’s Biggest News of 2024: Stories, Videos, and More
Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top 10.
Related Articles
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study
Study evaluates the diagnostic yield of an advanced invasive diagnosis strategy in chronic coronary syndrome patients referred for invasive coronary angiography.
Boston Scientific Announces Acquisition Agreement for Bolt Medical – Endovascular Today
January 8, 2025—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer
Preventing Contrast-induced Renal Failure: A Guide
Contrast-induced acute kidney injury (CI-AKI) is characterised by a rapid deterioration of renal function within a few days of parenteral administration of contrast media (CM)…
Dietary restriction impacts health and lifespan of genetically diverse mice
Nature – Health effects of dietary restriction are uncoupled from longevity.
HeartTalk Video: Navigating Remote Monitoring in an Evolving Cardiac Care Landscape
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions.
Semaglutide Improves CV Outcomes in Patients With History of CABG and Obesity | JACC | AHA 2024
JACC Associate Editor Marc P. Bonaca, MD, FACC, speaks with author Subodh Verma, MD, PhD, and A. Michael A. Lincoff, MD, FACC, about this brief…
No One Talks about Vasoplegia
This webinar will discuss pathophysiology of vasoplegia and its implications in the management of patients receiving short and long-term mechanical circulatory support. Finally, we will…
The Extravascular Implantable Cardioverter-Defibrillator: A Promising Novel Device – American College of Cardiology
The extravascular implantable cardioverter-defibrillator (EV-ICD) effectively terminates ventricular arrhythmias and can be implanted safely. The substernal position of the EV-ICD lead allows for antitachycardia pacing…
Valve Disease and HCM: Predicting and Preventing Complications
Podcast Episode · In the Thick of It · 01/08/2025 · 33m
Sex differences in ST-segment elevation myocardial infarction patients treated by primary percutaneous intervention
Introduction The impact of sex on coronary artery disease prognosis is debated. It has been postulated that women receive less prompt treatment compared with men,…
